Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel
Ticagrelor (TIC), a P2Y purinoceptor 12 (P2Y12)-receptor antagonist, has been widely used to treat patients with acute coronary syndrome. Although animal studies suggest that TIC protects against atherosclerosis, it remains unknown whether it does so through its potent platelet inhibition or through...
Published in: | PLoS ONE |
---|---|
Main Author: | Halim H.; Pinkaew D.; Chunhacha P.; Sinthujaroen P.; Thiagarajan P.; Fujise K. |
Format: | Article |
Language: | English |
Published: |
Public Library of Science
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068896088&doi=10.1371%2fjournal.pone.0218934&partnerID=40&md5=29af71b69c8eb7b2ecc963c0b96ad4bc |
Similar Items
-
Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of mice
by: Musa M.; Wilson K.; Sun L.; Mulay A.; Bingle L.; Marriott H.M.; LeClair E.E.; Bingle C.D.
Published: (2012) -
Mitigating DBA Exploits: Enhanced Security Against Degradation Attacks in XG-PON
by: Atan F.M.; Zulkifli N.; Idrus S.M.; Zin N.A.M.; Ismail N.A.
Published: (2024) -
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
by: Watts G.F.; Gidding S.S.; Hegele R.A.; Raal F.J.; Sturm A.C.; Jones L.K.; Sarkies M.N.; Al-Rasadi K.; Blom D.J.; Daccord M.; de Ferranti S.D.; Folco E.; Libby P.; Mata P.; Nawawi H.M.; Ramaswami U.; Ray K.K.; Stefanutti C.; Yamashita S.; Pang J.; Thompson G.R.; Santos R.D.
Published: (2023) -
Anti-Inflammatory Effects of Thymoquinone in Atherosclerosis: A Mini Review
by: Leong X.-F.; Choy K.W.; Alias A.
Published: (2021) -
Structure–Activity Relationship Analysis of Flavonoids and Its Inhibitory Activity Against BACE1 Enzyme Toward a Better Therapy for Alzheimer’s Disease
by: Mohamed Yusof N.I.S.; Abdullah Z.L.; Othman N.; Mohd Fauzi F.
Published: (2022)